Navigating the Challenges of Shared Decision-Making in Amyloid Immunotherapy for Alzheimer's Disease.
European journal of neurology · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansAlzheimer DiseaseDecision Making, SharedImmunotherapyPatient ParticipationInformed ConsentAlzheimer's diseaseanti‐amyloid immunotherapiesconsentshared decision‐makingsupported decision‐makingHealthcare Decision-Making and RestraintsEthics in Clinical ResearchEthics and bioethics in healthcareshared decision-makinganti-amyloid therapylecanemabdonanemabinformed consentcognitive vulnerabilitysupported decision-makingpatient autonomytreatment decision-makingcognitive biasesstigmaexecutive dysfunctioninformation delivery
Come citare questo studio
Grâce François, Robin Michalon, Thomas Tannou, Philippe Damier, Sonia Desmoulin, Thibaud Lebouvier. (2026). Navigating the Challenges of Shared Decision-Making in Amyloid Immunotherapy for Alzheimer's Disease.. European journal of neurology. DOI: 10.1111/ene.70800
Consulta la pubblicazione originale ↗